72 related articles for article (PubMed ID: 25736758)
1. Use of fluorescence spectroscopy for quantitative investigations of ubiquitin interactions with the ubiquitin-binding domains of NEMO.
Dubosclard V; Fontan E; Agou F
Methods Mol Biol; 2015; 1280():321-37. PubMed ID: 25736758
[TBL] [Abstract][Full Text] [Related]
2. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
3. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
Wagner S; Carpentier I; Rogov V; Kreike M; Ikeda F; Löhr F; Wu CJ; Ashwell JD; Dötsch V; Dikic I; Beyaert R
Oncogene; 2008 Jun; 27(26):3739-45. PubMed ID: 18212736
[TBL] [Abstract][Full Text] [Related]
5. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.
Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F
J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029
[TBL] [Abstract][Full Text] [Related]
6. In vitro detection of NEMO-ubiquitin binding using DELFIA and microscale thermophoresis assays.
Vincendeau M; Krappmann D; Hadian K
Methods Mol Biol; 2015; 1280():311-20. PubMed ID: 25736757
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
8. Covalent modification of the NF-κB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro.
Hooper C; Jackson SS; Coughlin EE; Coon JJ; Miyamoto S
J Biol Chem; 2014 Nov; 289(48):33161-74. PubMed ID: 25296760
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
10. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.
Laplantine E; Fontan E; Chiaravalli J; Lopez T; Lakisic G; Véron M; Agou F; Israël A
EMBO J; 2009 Oct; 28(19):2885-95. PubMed ID: 19763089
[TBL] [Abstract][Full Text] [Related]
11. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.
Rahighi S; Ikeda F; Kawasaki M; Akutsu M; Suzuki N; Kato R; Kensche T; Uejima T; Bloor S; Komander D; Randow F; Wakatsuki S; Dikic I
Cell; 2009 Mar; 136(6):1098-109. PubMed ID: 19303852
[TBL] [Abstract][Full Text] [Related]
12. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains.
Agou F; Traincard F; Vinolo E; Courtois G; Yamaoka S; Israël A; Véron M
J Biol Chem; 2004 Jul; 279(27):27861-9. PubMed ID: 15107419
[TBL] [Abstract][Full Text] [Related]
13. The role of ubiquitin-binding domains in human pathophysiology.
Sokratous K; Hadjisavvas A; Diamandis EP; Kyriacou K
Crit Rev Clin Lab Sci; 2014 Oct; 51(5):280-90. PubMed ID: 24901807
[TBL] [Abstract][Full Text] [Related]
14. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
15. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
Zhu G; Wu CJ; Zhao Y; Ashwell JD
Curr Biol; 2007 Aug; 17(16):1438-43. PubMed ID: 17702576
[TBL] [Abstract][Full Text] [Related]
16. Molecular Recognition of M1-Linked Ubiquitin Chains by Native and Phosphorylated UBAN Domains.
Herhaus L; van den Bedem H; Tang S; Maslennikov I; Wakatsuki S; Dikic I; Rahighi S
J Mol Biol; 2019 Aug; 431(17):3146-3156. PubMed ID: 31247202
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
Shifera AS
J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
[TBL] [Abstract][Full Text] [Related]
18. Linear ubiquitin chain-binding domains.
Fennell LM; Rahighi S; Ikeda F
FEBS J; 2018 Aug; 285(15):2746-2761. PubMed ID: 29679476
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
20. Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis.
Said Halidi KN; Fontan E; Boucharlat A; Davignon L; Charpentier M; Boullé M; Weil R; Israël A; Laplantine E; Agou F
iScience; 2019 Oct; 20():292-309. PubMed ID: 31605944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
